Patheon
Patheon
Patheon is a global provider of pharmaceutical development and manufacturing services. It is part of the Thermo Fisher Scientific company, which is a leader in serving science, with a mission to enable customers to make the world healthier, cleaner, and safer.
History
Patheon was founded in 1974 in Canada and has grown to become a leading provider of contract development and manufacturing services to the pharmaceutical and biotechnology industries. Over the years, Patheon has expanded its capabilities and global reach through strategic acquisitions and partnerships.
Services
Patheon offers a wide range of services that cover the entire spectrum of pharmaceutical development and manufacturing. These services include:
- Drug Substance Services: Patheon provides active pharmaceutical ingredient (API) development and manufacturing services, including small molecule and biologics.
- Drug Product Services: This includes formulation development, clinical trial material manufacturing, and commercial manufacturing for a variety of dosage forms such as tablets, capsules, and injectables.
- Development Services: Patheon offers comprehensive development services, including preformulation, formulation, analytical development, and clinical trial supply.
- Commercial Manufacturing: Patheon provides large-scale commercial manufacturing services, ensuring quality and compliance with regulatory standards.
Global Presence
Patheon operates a network of facilities across North America, Europe, Asia, and Australia. This global presence allows Patheon to serve clients worldwide and provide flexible solutions tailored to the needs of different markets.
Integration with Thermo Fisher Scientific
In 2017, Patheon was acquired by Thermo Fisher Scientific, a world leader in serving science. This acquisition has allowed Patheon to leverage Thermo Fisher's extensive resources and expertise, enhancing its service offerings and expanding its capabilities in the pharmaceutical and biotechnology sectors.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
